Literature DB >> 31231704

Proteomic heterogeneity reveals SOAT1 as a potential biomarker for hepatocellular carcinoma.

Subreen A Khatib1,2, Xin Wei Wang1,3.   

Abstract

Entities:  

Year:  2019        PMID： 31231704      PMCID： PMC6556685          DOI： 10.21037/tgh.2019.05.09

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  3 in total

Review 1.  Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Authors:  Li-Wei Qiu; Yi-Fei Liu; Xiao-Qing Cao; Yan Wang; Xiao-Hong Cui; Xian Ye; Shuo-Wen Huang; Hong-Jun Xie; Hai-Jian Zhang
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

2.  Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma.

Authors:  Yulong Chen; Xunjun Yang; Yao Chen; Guorong Chen; Cheryl A Winkler; Ping An; Jianxin Lyu
Journal:  BMC Cancer       Date:  2021-05-26       Impact factor: 4.430

3.  Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis.

Authors:  Chun-Chia Cheng; Wan-Yu Yang; Ming-Chen Hsiao; Kuan-Hao Lin; Hao-Wei Lee; Chiou-Hwa Yuh
Journal:  Biomolecules       Date:  2020-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.